Physician profile
Robert G Jones
NPI 1164465647
$889.99
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $38.71 · 2021: $120 · 2022: $214 · 2023: $66.33 · 2024: $87.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124 · Education: $30.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.74 |
| Education | $30.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $180.32 | 2022-2024 | Stelara |
| Pfizer INC. | $136.11 | 2019-2024 | |
| Abbvie INC. | $126.77 | 2019-2023 | |
| Digestive Care, INC. | $81.58 | 2019 | |
| Gilead Sciences, INC. | $69.38 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.80 | 2020-2021 | |
| Boston Scientific Corporation | $55.97 | 2019-2021 | |
| Allergan, INC. | $45.40 | 2019 | |
| Merck Sharp & Dohme LLC | $37.90 | 2019-2020 | |
| Ucb, INC. | $18.88 | 2019 | |
| Qol Medical, LLC | $16.47 | 2019 | |
| Organon LLC | $15.37 | 2021 | |
| Alexion Pharmaceuticals, INC. | $13.14 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.95 | 2021 | |
| Intercept Pharmaceuticals, INC. | $11.95 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,973.95 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.